There’s no denying that GLP-1 medications like Ozempic and Wegovy are having a moment. You’ve probably seen the headlines, ...

As Ozempic and other GLP-1 drugs explode in popularity, driven by their off-label use for rapid weight loss and viral social media trends, the pharmaceutical industry faces unprecedented challenges.

Ask a Doctor is new series of physician-authored columns offering insights and advice on common health topics. It is not a ...

Novo Nordisk has experienced a 50% drop due to potential tariffs and recent clinical trial results. Read why I rate NVO stock a strong buy right now.

A MOTHER has revealed that she has lost 10 and a half stone after using Mounjaro.  Becca Banks, a mum-of-one from the UK, ...

Ozempic side effects are reportedly leaving people looking like "melted candles", as plastic surgeons are reporting a surge ...

Oral semaglutide, already approved for type 2 diabetes, led to a reduction in CV events in patients with established ...

Findings from the American College of Cardiology 2025 Annual Scientific Session show oral semaglutide reduces the risk of heart attack, stroke, and cardiovascular death by 14% in patients with type 2 ...

As a federal crackdown on Ozempic-style copycats looms, Hims is trying a unique new strategy to lobby lawmakers.

given that GLP-1 drugs have generally been shown to be less effective at reducing weight in diabetics. It was a dose-ranging study, and the range of weight loss seen with Lilly’s drug was 9.4% ...